using a nano-LC-MS/MS-based proteomics approach speculated that SAA might be a biomarker of AA amyloidosis in rheumatoid arthritis; gelsolin and VDBP might be potent biomarker candidates for the early diagnosis of RA (10). This evidence concerns the gene SAA1 and rheumatoid arthritis.